NEWARK, Del., Aug. 20, 2026 — The global Heart Failure Drugs Market is expanding as healthcare providers increasingly adopt guideline-directed medical therapy and earlier pharmacological intervention for patients with heart failure. According to Future Market Insights (FMI), the market is projected to grow from USD 18.8 billion in 2026 to USD 37.0 billion by 2036, registering a 7.0% CAGR...